Veristat Appoints New Chief Commercial Officer
Veristat, the Science-First Full Service CRO and Consultancy, announced an appointment to its executive leadership team. Rachel Page joins Veristat as Chief Commercial Officer (CCO), succeeding Veristat’s longtime leader Cindy Henderson, who recently transitioned to become Chief Strategy Officer (CSO) to focus on developing and executing Veristat’s customer-driven corporate strategy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523499154/en/
Rachel Page, Chief Commercial Officer, Veristat (Photo: Business Wire)
With over two decades of experience in global health and science commercialization, Rachel is poised to energize our brand and leverage our deep industry expertise. Her role will be crucial in assisting biopharmaceutical companies as they navigate their most complex clinical and regulatory challenges to speed the delivery of innovative therapies.
“Veristat has a 30-year history of driving innovative approaches that help deliver what are often breakthrough therapies to patients in need,” stated Patrick Flanagan, Chief Executive Officer. “Rachel’s accomplishments and experience empowering people, building commercial organizations, and fostering trusted client relationships demonstrate her ability to successfully lead the execution of our strategic plan. Rachel has received tremendous recognition for her unwavering commitment to client success. I am confident in her ability to leverage Veristat’s deep industry experience on a global scale.”
Rachel’s extensive global network and her successful history in all phases of the pharmaceutical lifecycle will be instrumental in delivering impactful results for our clients.
"I am thrilled to join this dynamic, science-driven team," Rachel commented. "Veristat is exceptional at facilitating the delivery of crucial therapies and transforming client operations. I am honored to collaborate with such a passionate group of executives, colleagues, and clients who are dedicated to accelerating the availability of groundbreaking treatments for patients with complex conditions. I am eager to lead our talented global commercial team and contribute to achieving our clients’ vital objectives."
In her new role, Rachel will oversee Veristat’s commercialization strategy and operations, including business development, proposals, contracts, marketing, and fostering robust client relationships. She will also focus on the growth and development of the commercial team, ensuring continued success in meeting our clients’ needs.
About Veristat
Veristat is the Science-First CRO™ and Consultancy that integrates full service clinical trial execution, regulatory affairs and safety, and strategic advisor services to rapidly advance the development, approval, and commercialization of novel therapies (#NovelTherapies) around the globe. With 30 years of experience solving sponsors' unique and complex clinical, statistical, and regulatory challenges, Veristat Science-First experts deliver timely, quality-driven results with solutions that are tailored to the needs of patients, clinical trial sites, regulators, sponsor teams, and key stakeholders.
Veristat's focus on novel drug development has led to success when handling any unknown that arises, from the simplest to most complex, across numerous therapeutic areas including rare/ultra-rare disease, advanced therapies, oncology, and biologics including cell and gene therapies (#cellandgenetherapy), enabling sponsors to succeed in extending and saving patients’ lives. Sponsors collaborate with Veristat Science-First experts who care— like they do. It is not just business for Veristat, it’s personal.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240523499154/en/
Contact information
Veristat:
Lauren L. Brennan, Vice President of Marketing, Veristat
media@veristat.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cessna Citation X and X+ Customers Benefit From Starlink High-Speed Internet Availability13.3.2025 16:00:00 CET | Press Release
Textron Aviation today announced an additional high-speed internet connectivity solution for the Cessna Citation X and X+ following the Federal Aviation Administration’s (FAA) issuance of AeroMech’s Supplemental Type Certificate (STC) for Starlink high-speed internet connectivity. AeroMech’s STC utilizes Starlink’s constellation of Low Earth Orbit (LEO) satellites to provide more reliable connectivity over land, water and remote areas, where traditional in-flight Wi-Fi may not have service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313683324/en/ Textron Aviation announced an additional high-speed internet connectivity solution for the Cessna Citation X and X+ following the Federal Aviation Administration’s (FAA) issuance of AeroMech’s Supplemental Type Certificate (STC) for Starlink high-speed internet connectivity. (Photo Credit: Textron Aviation) Beechcraft, Cessna and Hawker customers receive factory-direct suppor
ClickHouse Acquires HyperDX to Accelerate the Future of Observability13.3.2025 16:00:00 CET | Press Release
ClickHouse, the company behind the world's fastest analytical database, today announced the acquisition of HyperDX, an open-source observability platform built on ClickHouse. This strategic acquisition reinforces ClickHouse's commitment to delivering the fastest, most cost-effective, and scalable solutions to developers and enterprises worldwide; including observability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313954782/en/ ClickHouse, the company behind the world's fastest analytical database, today announced the acquisition of HyperDX, an open-source observability platform built on ClickHouse. (Graphic: Business Wire) The acquisition combines ClickHouse's unmatched performance and scalability with HyperDX's developer-first experience, creating a comprehensive observability platform that seamlessly integrates session replay, exceptions, logs, infrastructure metrics, and distributed tracing through an OpenTelemetry
Credit Derivatives Determinations Committees Membership Applications for 202513.3.2025 15:33:00 CET | Press Release
DC Administration Services, Inc. (DCAS) would like to invite all interested Members of ISDA to apply for a position as a member of the Credit Derivatives Determinations Committees. There is a separate Determinations Committee for each of the relevant regions. Members of ISDA may apply for membership as either a Dealer Member of the Determinations Committees or a Non-Dealer Member of the Determinations Committees (as applicable). Parties wishing to apply for such a position should carefully review and submit either an executed Dealer Participation Letter (for a prospective Dealer Member) or an executed Non-dealer Committee Participation Letter (for a prospective Non-Dealer Member) by 5pm (New York time) on Wednesday, March 19, 2025. CCPs may also apply to participate as a CCP Member by submitting a Participating CCP Institution Letter. For more information on the process and to download the form of the relevant letter, please visit https://www.cdsdeterminationscommittees.org/about-dc-co
REPLY: The Board of Directors Approved the Draft Financial Statements for the Year 202413.3.2025 15:17:00 CET | Press Release
Today the Board of Directors of Reply S.p.A. [MTA, STAR: REY] approved the draft financial statement for the year 2024, which will be submitted for approval to the Shareholders’ Meeting to be held in a single call in Turin on 23 April 2025. The Reply Group closed 2024 with a consolidated turnover of €2,295.9 million an increase of 8.4% compared to €2,118.0 million in 2023. All indicators are positive for the period. Consolidated EBITDA was €410.6 million, an increase of 16.6% compared to €352.1 million at December 2023. EBIT, from January to December, was at €330.4 million, which is an increase of 12.9% compared to €292.7 million at December 2023. The Group net profit was at €211.1 million. In 2023, the corresponding value was €186.7 million. Following the results achieved in 2024, the Reply Board of Directors decided to propose a dividend distribution of €1.15 per share to the next Shareholders’ Meeting, which will be payable on 21 May 2025, with the dividend date set on 19 May 2025 (
China’s Huangshan, a UNESCO Dual Heritage Site, Promotes Tourism in Paris13.3.2025 15:00:00 CET | Press Release
Under the theme “Huangshan & Paris: A Magnificent Encounter of World Heritage,” Huangshan Tourism Development Co., Ltd. (HSTD), the operator of Huangshan Mountain, recently hosted a promotional event in Paris to showcase its rich tourism resources and the deep cultural heritage of Huizhou. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250313136766/en/ Zhang Dehui, president of Huangshan Tourism Development Co., Ltd., delivered a speech at the event. (Photo: Business Wire) "When the classical aesthetics of the Louvre meet the picturesque landscapes of Huangshan, when the vineyards of Bordeaux intertwine with the rolling green waves of Huizhou’s tea gardens, this cultural and tourism dialogue spanning the Eurasian continent is destined to compose a new chapter," said Zhang Dehui, President of HSTD, as he welcomed guests and introduced Huangshan’s abundant tourism offerings. The event drew dozens of representatives from Chines
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom